Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
- Specification
- Q & A
- Customer Review
Treatment options for ovarian cancer may include surgery to remove the tumors and affected organs, chemotherapy to destroy cancer cells, targeted therapy drugs that specifically target certain genetic mutations, and radiation therapy in some cases.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
High yield
The cell product had a high yield, making it a cost-effective choice for our research.
06 June 2023
Ease of use
After sales services
Value for money
Write your own review
Description: Species: human female 60 years old;
Tissue: ovary;
Tumor: adenocarcinoma, low differentiated;
G3 FIGO stage IV (pleural metastasis);
Derived from: ascitic fluid
Description: Established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979; initially diploid, later tetraploid; growth in nude mice
Description: Established from the ascites fluid stemming from the colon metastasis of a 46-year-old white woman with ovarian adenocarcinoma in 1986
Description: Established from the ascitic fluid of a 56-year-old Caucasian woman with dedifferentiated serous cystadenocarcinoma of the ovary in 1979
Description: Established post-hysterectomy from the tumor tissue of a 65-year-old Japanese woman with malignant ovarian carcinoma (stage: FIGO IIIc; histology: poorly differentiated serous papillary adenocarcinoma) in 1989
Description: Established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary.
